Author/Authors :
Karimi Dermani, F Research Center for Molecular Medicine - Hamadan University of Medical Sciences - Hamadan, Iran , Saidijam, M Research Center for Molecular Medicine - Hamadan University of Medical Sciences - Hamadan, Iran , Najafi, R Research Center for Molecular Medicine - Hamadan University of Medical Sciences - Hamadan, Iran , Moradkhani, Shirin Department of pharmacognosy - School of Pharmacy - Hamadan University of Medical Sciences - Hamadan, Iran , Mohammadzaheri, Z Department of Pharmacology and Toxicology - School of Pharmacy - Hamadan University of Medical Sciences - Hamadan, Iran , Beiranvand, N Department of Pharmacology and Toxicology - School of Pharmacy - Hamadan University of Medical Sciences - Hamadan, Iran , Mohammadi, S Department of pharmacognosy - School of Pharmacy - Hamadan University of Medical Sciences - Hamadan, Iran , Shabab, Noushin Research Center for Molecular Medicine - Hamadan University of Medical Sciences - Hamadan, Iran , Kalvandi, Ramazan Natural Resources Department - Hamadan Agricultural and Natural Resources Research and Education Center - AREEO - Hamadan, Iran , Zeraati, F Department of Pharmacology and Toxicology - School of Pharmacy - Hamadan University of Medical Sciences - Hamadan, Iran
Abstract :
Chemoprevention of cancer by application of natural
phytochemical compounds has been used to prevent, delay or
suppress cancer progression. Cuscuta chinensis a traditional Iranian
medicinal herb, has biological properties including anticancer, antiaging,
immuno-stimulatory and antioxidant effects. In this study,
anti-proliferative effects of hydroalcoholic extract of C. chinensis
on prostate (PC3) and breast (MCF7) cancer cell lines were
investigated.
Materials and Methods: In the current study, we investigated
treatment of PC3 cells with different concentrations of C. chinensis
(0, 100, 200, 300, 400, and 500 μg/ml) for 24 and 48 hr; also, MCF7
cells were treated with various concentrations (0-600 μg/ml) of C.
chinensis for 48 and 72 hr and cell viability was assessed by 3-(4,
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT)
assay. mRNA expression of BCL2 Associated X (Bax), B-cell
lymphoma 2 (Bcl2), Cysteine-aspartic proteases (Caspase3) and
Phosphatase and tensin homolog (PTEN) were analyzed by
quantitative real-time PCR. Annexin V/PI staining and lactate
dehydrogenase (LDH) cytotoxicity assay were used to detect
apoptosis.
Results: C. chinensis decreased PC3 and MCF7 cells viability in a
dose- and time-dependent manner (p<0.01 to p<0.001). The gene
expression of BAX/Bcl2 ratio, Caspase3 and PTEN increased in C.
chinensis-treated cells compared to the control group. C. chinensis
induced apoptosis (p<0.001) and LDH activity (p<0.01 to p<0.001).
Conclusion: Our findings suggest that C. chinensis extract is able
to inhibit proliferation and induce apoptosis in PC3 and MCF7 cell
lines. Therefore, C. chinensis extract exerts antitumor activity
against cancer cells.
Keywords :
Cuscuta . chinensis , Chemoprevention , Prostate cancer , Breast cancer , Apoptosis